Literature DB >> 1053934

Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.

L J Rubinstein, M M Herman, T F Long, J R Wilbur.   

Abstract

This report describes a form of disseminated necrotizing leukoencephalopathy that has been observed in four children with acute lymphoblastic leukemia, and one child with Burkitt's lymphoma terminating in a leukemic phase. In addition to systemic vincristine, cytosine arabinoside, cyclophosphamide, and steroids, these patients received courses of intrathecal methotrexate, cytosine arabinoside, and hydrocortisone, because of meningeal tumor cell infiltration. Whole brain radiation was also given either before or during intrathecal therapy. Three of the children had a progressive irreversible neurologic illness, which developed either at or shortly after the completion of combined triple intrathecal therapy, death ensuing approximately 2 months later. The neuropathologic lesions consisted of discrete multifocal necroses of coagulative type, apparently extending by confluence, and disseminated in the cerebral white matter in a random manner. In one case, extensive symmetrical demyelinating and necrotizing lesions involved the centrum ovale bilaterally. There was a remarkable absence of inflammatory cellular response and a relative paucity of macrophage reaction, with usually little or no tissue breakdown. In addition to demyelination and glial cell loss, there was striking axonal damage, with conspicuous axonal swelling both within and around the necrotizing lesions. The surrounding white matter showed focal status spongiosus and a moderate astrocytic response. Vascular fibrinoid necrosis was inconstant and, except in one case, rarely observed. The possible causal relationship of these lesions to combined triple intrathecal antimetabolite therapy and brain radiation is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1053934     DOI: 10.1002/1097-0142(197502)35:2<291::aid-cncr2820350202>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  71 in total

1.  Akinetic mutism in bilateral necrotizing leucoencephalopathy after radiation and chemotherapy: electrophysiological and autopsy findings.

Authors:  E Gütling; T Landis; P Kleihues
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

2.  Case files of the New York City Poison Control Center: antidotal strategies for the management of methotrexate toxicity.

Authors:  Silas W Smith; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2008-06

3.  Reversal of CNS-prophylaxis-related leukoencephalopathy after CSF shunting: case histories of identical twins.

Authors:  I H Tekkök; D A Carter; M G Robinson; R Brinker
Journal:  Childs Nerv Syst       Date:  1996-06       Impact factor: 1.475

Review 4.  Atypical MRI findings in treatment-related leukoencephalopathy: case report.

Authors:  Y Ohmoto; K Kajiwara; S Kato; T Nisizaki; H Ito; S Tamura
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

5.  Multifocal Necrotizing Leukoencephalopathy With Preferential Microglia Toxicity in a Patient Treated With Chimeric Antigen Receptor T-Cells and Review of the Literature.

Authors:  Daniel F Marker; Julia K Kofler; Joseph A Mettenburg; Mounzer E Agha; Clayton A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  2020-10-01       Impact factor: 3.685

6.  Involvement of the central nervous system in malignant lymphomas.

Authors:  K Jellinger; T Radiaszkiewicz
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-07-21

7.  Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors.

Authors:  Irene Slavc; Elisabeth Schuller; Jutta Falger; Mehmet Günes; Konrad Pillwein; Thomas Czech; Wolfgang Dietrich; Karl Rössler; Karin Dieckmann; Daniela Prayer; Johannes Hainfellner
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

8.  Neurological complications of childhood leukaemia.

Authors:  R H Campbell; W C Marshall; J M Chessells
Journal:  Arch Dis Child       Date:  1977-11       Impact factor: 3.791

9.  Treatment of overt meningeal leukaemia in children: results of second MRC meningeal leukaemia trial.

Authors:  M L Willoughby
Journal:  Br Med J       Date:  1976-04-10

10.  Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.

Authors:  J M Chessells; T C Cox; B Kendall; N P Cavanagh; L Jannoun; S Richards
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.